A Phase I Trial of PVSRIPO for Patients With Unresectable Melanoma
Phase of Trial: Phase I
Latest Information Update: 01 Nov 2019
Price : $35 *
At a glance
- Drugs Recombinant polio virus vaccine Istari Oncology (Primary)
- Indications Malignant melanoma
- Focus Adverse reactions
- Sponsors Istari Oncology
- 24 Oct 2019 Planned number of patients changed from 9 to 12.
- 26 Nov 2018 Status changed from not yet recruiting to recruiting.
- 25 Oct 2018 New trial record